Harrisburg’s decision in early April to legalize medical marijuana in the state of Pennsylvania has set several wheels in motion, including those at the Department of Health, which has six months, beginning on May 17, to craft the necessary regulations.
Leaping into the fray is U.S. Cannabis Pharmaceutical Research and Development, which hosted two business seminars this past weekend in Philadelphia and West Conshohocken, giving citizens an opportunity to learn more about the legislation and explore the many ways they might take advantage of a new business opportunity.
Established in 2009, the USCPRD seeks to facilitate the legalization of medical marijuana in all states through multi-disciplinary education that spans the many facets of the industry. The organization has been active in several states with new legislation concerning the sale and consumption of marijuana for medicinal purposes, most recently adding Pennsylvania to the list. According to Michael Patterson, the organization’s CEO, Pennsylvania’s legislation will become a template for other states attempting to legalize medical marijuana, including Florida and Ohio.
“PA is ground zero for the way this movement should move forward in a responsible way,” Patterson told Philadelphia magazine. [Read more at Philadelphia magazine]